BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hämmerling GJ, David CS. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 1996;184:1167-72. [PMID: 9064334 DOI: 10.1084/jem.184.3.1167] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Angyalosi G, Neveu R, Wolowczuk I, Delanoye A, Herno J, Auriault C, Pancré V. HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice. Infect Immun 2001;69:5874-82. [PMID: 11500466 DOI: 10.1128/IAI.69.9.5874-5882.2001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Muixí L, Alvarez I, Jaraquemada D. Peptides presented in vivo by HLA-DR in thyroid autoimmunity. Adv Immunol 2008;99:165-209. [PMID: 19117535 DOI: 10.1016/S0065-2776(08)00606-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology 2008;135:2107-18. [PMID: 18773898 DOI: 10.1053/j.gastro.2008.07.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
4 Pennesi G, Mattapallil MJ, Sun SH, Avichezer D, Silver PB, Karabekian Z, David CS, Hargrave PA, McDowell JH, Smith WC, Wiggert B, Donoso LA, Chan CC, Caspi RR. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest 2003;111:1171-80. [PMID: 12697736 DOI: 10.1172/JCI15155] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 2003;36:367-79. [PMID: 14669944 DOI: 10.1080/08916930310001603037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
6 Jawa V, Cousens LP, Awwad M, Wakshull E, Kropshofer H, De Groot AS. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation. Clin Immunol 2013;149:534-55. [PMID: 24263283 DOI: 10.1016/j.clim.2013.09.006] [Cited by in Crossref: 166] [Cited by in F6Publishing: 147] [Article Influence: 20.8] [Reference Citation Analysis]
7 Dasgupta S, Bayry J, André S, Dimitrov JD, Kaveri SV, Lacroix-Desmazes S. Auditing protein therapeutics management by professional APCs: toward prevention of immune responses against therapeutic proteins. J Immunol 2008;181:1609-15. [PMID: 18641295 DOI: 10.4049/jimmunol.181.3.1609] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
8 Madsen L, Labrecque N, Engberg J, Dierich A, Svejgaard A, Benoist C, Mathis D, Fugger L. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A 1999;96:10338-43. [PMID: 10468609 DOI: 10.1073/pnas.96.18.10338] [Cited by in Crossref: 241] [Cited by in F6Publishing: 238] [Article Influence: 11.0] [Reference Citation Analysis]
9 Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003;24:694-717. [PMID: 14570752 DOI: 10.1210/er.2002-0030] [Cited by in Crossref: 269] [Cited by in F6Publishing: 237] [Article Influence: 15.8] [Reference Citation Analysis]
10 Pichurin P, Pham N, David CS, Rapoport B, McLachlan SM. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism. Thyroid 2006;16:1221-7. [PMID: 17199432 DOI: 10.1089/thy.2006.16.1221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
11 Kong YC. Experimental autoimmune thyroiditis in the mouse. Curr Protoc Immunol 2007;Chapter 15:Unit 15.7. [PMID: 18432986 DOI: 10.1002/0471142735.im1507s78] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pulido JS, Streilein JW. HLA and Eye Disease. HLA in Health and Disease. Elsevier; 2000. pp. 279-97. [DOI: 10.1016/b978-012440315-4/50094-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Flynn JC, Wan Q, Panos JC, McCormick DJ, Giraldo AA, David CS, Kong YC. Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis. J Autoimmun 2002;18:213-20. [PMID: 12126634 DOI: 10.1006/jaut.2002.0587] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
14 Osen W, Soltek S, Song M, Leuchs B, Steitz J, Tüting T, Eichmüller SB, Nguyen XD, Schadendorf D, Paschen A. Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries. PLoS One 2010;5:e14137. [PMID: 21152437 DOI: 10.1371/journal.pone.0014137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jacobson EM, Concepcion E, Ho K, Kopp P, Vono Toniolo J, Tomer Y. cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity. PLoS One 2011;6:e19200. [PMID: 21559421 DOI: 10.1371/journal.pone.0019200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
16 De Groot AS, Scott DW. Immunogenicity of protein therapeutics. Trends in Immunology 2007;28:482-90. [DOI: 10.1016/j.it.2007.07.011] [Cited by in Crossref: 339] [Cited by in F6Publishing: 293] [Article Influence: 24.2] [Reference Citation Analysis]
17 Kong YC, Flynn JC. Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1. Front Immunol 2014;5:206. [PMID: 24904570 DOI: 10.3389/fimmu.2014.00206] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 10.1] [Reference Citation Analysis]
18 Li CW, Osman R, Menconi F, Concepcion ES, Tomer Y. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J Autoimmun 2017;76:1-9. [PMID: 27670087 DOI: 10.1016/j.jaut.2016.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
19 Kong Y, David CS. New Revelations in Susceptibility to Autoimmune Thyroiditis by the Use of H2 and HLA Class II Transgenic Models. International Reviews of Immunology 2009;19:573-85. [DOI: 10.3109/08830180009088513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
20 Yuksel M, Wang Y, Tai N, Peng J, Guo J, Beland K, Lapierre P, David C, Alvarez F, Colle I, Yan H, Mieli-Vergani G, Vergani D, Ma Y, Wen L. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology. 2015;62:1536-1550. [PMID: 26185095 DOI: 10.1002/hep.27998] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
21 Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008;30:58-62. [PMID: 18178059 DOI: 10.1016/j.jaut.2007.11.010] [Cited by in Crossref: 158] [Cited by in F6Publishing: 147] [Article Influence: 12.2] [Reference Citation Analysis]
22 Pichurin P, Chen C, Pichurina O, David C, Rapoport B, Mclachlan SM. Thyrotropin Receptor-DNA Vaccination of Transgenic Mice Expressing HLA-DR3 or HLA-DQ6b. Thyroid 2003;13:911-7. [DOI: 10.1089/105072503322511300] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
23 Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005;2:1. [PMID: 15762980 DOI: 10.1186/1740-2557-2-1] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
24 Kong YC, Flynn JC, Banga JP, David CS. Application of HLA class II transgenic mice to study autoimmune regulation. Thyroid 2007;17:995-1003. [PMID: 17900224 DOI: 10.1089/thy.2007.0196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
25 Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, Fleva A, Gerofotis A, Karadani N, Yovos JG. Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes’ associations of Hashimoto’s thyroiditis in a Greek population. Tissue Antigens. 2009;73:199-205. [PMID: 19254248 DOI: 10.1111/j.1399-0039.2008.01182.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
26 Mangalam AK, Rajagopalan G, Taneja V, David CS. HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol 2008;97:65-147. [PMID: 18501769 DOI: 10.1016/S0065-2776(08)00002-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
27 Coppola M, van den Eeden SJ, Wilson L, Franken KL, Ottenhoff TH, Geluk A. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis. Clin Vaccine Immunol 2015;22:1060-9. [PMID: 26202436 DOI: 10.1128/CVI.00271-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
28 Wilbe M, Sundberg K, Hansen IR, Strandberg E, Nachreiner RF, Hedhammar A, Kennedy LJ, Andersson G, Björnerfeldt S. Increased genetic risk or protection for canine autoimmune lymphocytic thyroiditis in Giant Schnauzers depends on DLA class II genotype. Tissue Antigens 2010;75:712-9. [PMID: 20210920 DOI: 10.1111/j.1399-0039.2010.01449.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
29 Drescher KM, Nguyen LT, Taneja V, Coenen MJ, Leibowitz JL, Strauss G, Hammerling GJ, David CS, Rodriguez M. Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. J Clin Invest 1998;101:1765-74. [PMID: 9541508 DOI: 10.1172/JCI167] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
30 Flynn JC, Gilbert JA, Meroueh C, Snower DP, David CS, Kong YC, Banga JP. Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. Immunology 2007;122:261-7. [PMID: 17535305 DOI: 10.1111/j.1365-2567.2007.02635.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
31 Paschen A, Song M, Schenk S, Janda J, Nguyen XD, Osen W, Schadendorf D, Geginat G. Identification of a cross-reactive HLA-DRB1*0301-restricted CD4 T cell response directed against cholesterol-binding cytolysins from two different pathogens. Microbes Infect 2006;8:2034-43. [PMID: 16798043 DOI: 10.1016/j.micinf.2006.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
32 Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F. A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J Immunol Methods 2000;246:37-50. [PMID: 11121545 DOI: 10.1016/s0022-1759(00)00288-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong Yc. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum Immunol 2002;63:301-10. [PMID: 12039412 DOI: 10.1016/s0198-8859(02)00360-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
34 Rajagopalan G, Smart M, Cheng S, Krco C, Johnson K, David C. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M: David et al : Functions of DR3/DQ8 in H2-M-deficient mice. Tissue Antigens 2003;62:149-61. [DOI: 10.1034/j.1399-0039.2003.00088.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
35 Bounds CE, Terry FE, Moise L, Hannaman D, Martin WD, De Groot AS, Suschak JJ, Dupuy LC, Schmaljohn CS. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Hum Vaccin Immunother 2017;13:2824-36. [PMID: 28575582 DOI: 10.1080/21645515.2017.1329788] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
36 Kurimoto C, Inaba H, Ariyasu H, Iwakura H, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Morita S, Yamamoto Y, Yamashita S, Katsuda M, Hayata A, Akamatsu H, Jinnin M, Hara I, Yamaue H, Akamizu T. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors. Cancer Sci 2020;111:1468-77. [PMID: 32086984 DOI: 10.1111/cas.14363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
37 Gardyan A, Osen W, Zörnig I, Podola L, Agarwal M, Aulmann S, Ruggiero E, Schmidt M, Halama N, Leuchs B, von Kalle C, Beckhove P, Schneeweiss A, Jäger D, Eichmüller SB. Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice. Int J Cancer 2015;136:2588-97. [PMID: 25387692 DOI: 10.1002/ijc.29322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Cheng S, Smart M, Hanson J, David C. Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. Journal of Autoimmunity 2003;21:195-9. [DOI: 10.1016/s0896-8411(03)00120-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
39 Bugelski PJ. Genetic aspects of immune-mediated adverse drug effects. Nat Rev Drug Discov 2005;4:59-69. [DOI: 10.1038/nrd1605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
40 Carayanniotis G, Kong YC. Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis. Int Rev Immunol 2000;19:557-72. [PMID: 11129115 DOI: 10.3109/08830180009088512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
41 Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 2003;36:397-404. [PMID: 14669947 DOI: 10.1080/08916930310001603028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
42 Chowdhary VR, Dai C, Tilahun AY, Hanson JA, Smart MK, Grande JP, Rajagopalan G, Fu SM, David CS. A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus. J Immunol 2015;195:4660-7. [PMID: 26475924 DOI: 10.4049/jimmunol.1501073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
43 Abraham RS, David CS. Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice. Curr Opin Immunol 2000;12:122-9. [PMID: 10679410 DOI: 10.1016/s0952-7915(99)00060-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
44 Li CW, Menconi F, Osman R, Mezei M, Jacobson EM, Concepcion E, David CS, Kastrinsky DB, Ohlmeyer M, Tomer Y. Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis. J Biol Chem 2016;291:4079-90. [PMID: 26703475 DOI: 10.1074/jbc.M115.694687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
45 Canaday DH. Production of CD4⁺ and CD8⁺ T cell hybridomas. Methods Mol Biol 2013;960:297-307. [PMID: 23329495 DOI: 10.1007/978-1-62703-218-6_22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
46 Flynn JC, Mccormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YM. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cellular Immunology 2004;229:79-85. [DOI: 10.1016/j.cellimm.2004.07.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
47 Wan Q, Motte RW, Mccormick DJ, Fuller BE, Giraldo AA, David CS, Kong YM. Primary Hormonogenic Sites as Conserved Autoepitopes on Thyroglobulin in Murine Autoimmune Thyroiditis: Role of MHC Class II. Clinical Immunology and Immunopathology 1997;85:187-94. [DOI: 10.1006/clin.1997.4443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
48 Gershwin ME, Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011;37:59-62. [PMID: 21621385 DOI: 10.1016/j.jaut.2011.05.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
49 Moise L, Buller RM, Schriewer J, Lee J, Frey SE, Weiner DB, Martin W, De Groot AS. VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. Vaccine 2011;29:501-11. [PMID: 21055490 DOI: 10.1016/j.vaccine.2010.10.064] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
50 Ng HP, Paul Banga J, Kung AWC. Development of a Murine Model of Autoimmune Thyroiditis Induced with Homologous Mouse Thyroid Peroxidase. Endocrinology 2004;145:809-16. [DOI: 10.1210/en.2003-0656] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
51 Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J Immunol 2009;182:5873-81. [PMID: 19380836 DOI: 10.4049/jimmunol.0804074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
52 Karras E, Yang H, Lymberi P, Christadoss P. Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice. J Autoimmun 2005;24:291-6. [PMID: 15927791 DOI: 10.1016/j.jaut.2005.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
53 Kamdi AS, Kandavalli NB, Emusu D, Jain N, Mamtani M, Porterfield JR. Weak or absent evidence for the association of HLA-DR antigens with risk of thyroid carcinoma: a meta-analysis of observational studies. Tissue Antigens 2011;78:382-9. [DOI: 10.1111/j.1399-0039.2011.01754.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Kong YC, Jacob JB, Flynn JC, Elliott BE, Wei WZ. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun Rev 2009;9:28-33. [PMID: 19254781 DOI: 10.1016/j.autrev.2009.02.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
55 Flynn JC, Rao PV, Gora M, Alsharabi G, Wei W, Giraldo AA, David CS, Banga JP, Kong YM. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol 2004;135:35-40. [PMID: 14678262 DOI: 10.1111/j.1365-2249.2004.02333.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
56 Kong YM. Animal models of autoimmune thyroiditis: recent advances. In: Weetman AP, editor. Endocrine Autoimmunity and Associated Conditions. Dordrecht: Springer Netherlands; 1998. pp. 1-23. [DOI: 10.1007/978-94-011-5044-6_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
57 Inaba H, De Groot LJ, Akamizu T. Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease. Front Endocrinol (Lausanne) 2016;7:120. [PMID: 27602020 DOI: 10.3389/fendo.2016.00120] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
58 Rajagopalan G, Tilahun AY, Iijima K, David CS, Kita H, Juhn YJ. HLA-DR polymorphism modulates response to house dust mites in a transgenic mouse model of airway inflammation. Tissue Antigens 2011;77:589-92. [PMID: 21447115 DOI: 10.1111/j.1399-0039.2010.01617.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Reeves PM, Raju Paul S, Baeten L, Korek SE, Yi Y, Hess J, Sobell D, Scholzen A, Garritsen A, De Groot AS, Moise L, Brauns T, Bowen R, Sluder AE, Poznansky MC. Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling. Sci Rep 2020;10:13311. [PMID: 32770104 DOI: 10.1038/s41598-020-69327-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Moise L, Tassone R, Latimer H, Terry F, Levitz L, Haran JP, Ross TM, Boyle CM, Martin WD, De Groot AS. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice. Hum Vaccin Immunother 2013;9:2060-8. [PMID: 24045788 DOI: 10.4161/hv.26511] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
61 Edinger JW, Posnett DN. T-Cell Antigen Receptor Repertoire in Rheumatoid Arthritis. In: Paul S, editor. Autoimmune Reactions. Totowa: Humana Press; 1999. pp. 113-40. [DOI: 10.1007/978-1-4612-1610-0_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
62 Kong YC, Wei WZ, Tomer Y. Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation. Ann N Y Acad Sci 2010;1183:222-36. [PMID: 20146718 DOI: 10.1111/j.1749-6632.2009.05138.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
63 Stohl W, Xu D, Zang S, Kim KS, Li L, Hanson JA, Stohlman SA, David CS, Jacob CO. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II. Int Immunol 2001;13:1291-300. [PMID: 11581174 DOI: 10.1093/intimm/13.10.1291] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
64 Kong YC, Brown NK, Flynn JC, McCormick DJ, Brusic V, Morris GP, David CS. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. J Autoimmun 2011;37:63-70. [PMID: 21683551 DOI: 10.1016/j.jaut.2011.05.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Flynn JC, Fuller BE, Giraldo AA, Panos JC, David CS, Kong YC. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. J Autoimmun 2001;17:7-15. [PMID: 11488633 DOI: 10.1006/jaut.2001.0528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
66 Wei WZ, Jacob J, Radkevich-Brown O, Whittington P, Kong YC. The "A, B and C" of Her-2 DNA vaccine development. Cancer Immunol Immunother 2008;57:1711-7. [PMID: 18273615 DOI: 10.1007/s00262-008-0464-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
67 Brown NK, McCormick DJ, David CS, Kong YC. H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis. J Immunol 2008;180:7039-46. [PMID: 18453626 DOI: 10.4049/jimmunol.180.10.7039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
68 Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 2008;29:697-725. [PMID: 18776148 DOI: 10.1210/er.2008-0015] [Cited by in Crossref: 134] [Cited by in F6Publishing: 110] [Article Influence: 10.3] [Reference Citation Analysis]
69 Zhao J, Alshukairi AN, Baharoon SA, Ahmed WA, Bokhari AA, Nehdi AM, Layqah LA, Alghamdi MG, Al Gethamy MM, Dada AM, Khalid I, Boujelal M, Al Johani SM, Vogel L, Subbarao K, Mangalam A, Wu C, Ten Eyck P, Perlman S, Zhao J. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol 2017;2:eaan5393. [PMID: 28778905 DOI: 10.1126/sciimmunol.aan5393] [Cited by in Crossref: 143] [Cited by in F6Publishing: 137] [Article Influence: 35.8] [Reference Citation Analysis]
70 Bray-French K, Hartman K, Steiner G, Marban-Doran C, Bessa J, Campbell N, Martin-Facklam M, Stubenrauch KG, Solier C, Singer T, Ducret A. Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside. J Pharm Sci 2021;110:2575-84. [PMID: 33812888 DOI: 10.1016/j.xphs.2021.03.027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Mattapallil MJ, Silver PB, Mattapallil JJ, Horai R, Karabekian Z, McDowell JH, Chan CC, James EA, Kwok WW, Sen HN, Nussenblatt RB, David CS, Caspi RR. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J Immunol 2011;187:1977-85. [PMID: 21765017 DOI: 10.4049/jimmunol.1101247] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
72 Susukida T, Aoki S, Shirayanagi T, Yamada Y, Kuwahara S, Ito K. HLA transgenic mice: application in reproducing idiosyncratic drug toxicity. Drug Metab Rev 2020;52:540-67. [PMID: 32847422 DOI: 10.1080/03602532.2020.1800725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Geluk A, Taneja V, van Meijgaarden KE, de Vries RRP, David CS, Ottenhoff THM. HLA-DR/DQ Transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential. Biotherapy 1998;10:191-6. [DOI: 10.1007/bf02678296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 de la Concha EG, Fernandez-Arquero M, Martinez A, Vigil P, Vidal F, Lopez-Nava G, Diaz-Rubio M, Garcia-Paredes J. Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis. Dig Dis Sci. 1999;44:2324-2329. [PMID: 10573382 DOI: 10.1023/a:1026629409481] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Taneja V, David CS. HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 1998;101:921-6. [PMID: 9486959 DOI: 10.1172/JCI2860] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
76 McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014;35:59-105. [PMID: 24091783 DOI: 10.1210/er.2013-1055] [Cited by in Crossref: 99] [Cited by in F6Publishing: 81] [Article Influence: 12.4] [Reference Citation Analysis]
77 Kari S, Flynn JC, Zulfiqar M, Snower DP, Elliott BE, Kong YC. Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice. Thyroid 2013;23:1590-9. [PMID: 23777580 DOI: 10.1089/thy.2013.0064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
78 Taneja V, David CS. HLA class II transgenic mice as models of human diseases. Immunol Rev 1999;169:67-79. [PMID: 10450509 DOI: 10.1111/j.1600-065x.1999.tb01307.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
79 Sheen YH, Rajagopalan G, Snapper CM, Kita H, Wi CI, Umaretiya PJ, Juhn YJ. Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model. HLA 2016;88:25-34. [PMID: 27506953 DOI: 10.1111/tan.12851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
80 Shattuck WM, Dyer MC, Desrosiers J, Fast LD, Terry FE, Martin WD, Moise L, De Groot AS, Mather TN. Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice. Hum Vaccin Immunother 2014;10:3048-59. [PMID: 25517089 DOI: 10.4161/21645515.2014.985498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Morris GP, Yan Y, David CS, Kong YC. H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J Immunol 2005;174:3111-6. [PMID: 15728527 DOI: 10.4049/jimmunol.174.5.3111] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
82 Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, de Vries RR, David CS, Ottenhoff TH. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci U S A 1998;95:10797-802. [PMID: 9724784 DOI: 10.1073/pnas.95.18.10797] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
83 Whittington PJ, Radkevich-Brown O, Jacob JB, Jones RF, Weise AM, Wei WZ. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity. Cancer Immunol Immunother 2009;58:759-67. [PMID: 18836716 DOI: 10.1007/s00262-008-0599-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
84 Faraji F, Karjoo Z, Moghaddam MV, Heidari S, Emameh RZ, Falak R. Challenges related to the immunogenicity of parenteral recombinant proteins: Underlying mechanisms and new approaches to overcome it. Int Rev Immunol 2018;37:301-15. [PMID: 29851534 DOI: 10.1080/08830185.2018.1471139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
85 Yan Y, Panos JC, McCormick DJ, Wan Q, Giraldo AA, Brusic V, David CS, Kong YC. Characterization of a novel H2A(-)E+ transgenic model susceptible to heterologous but not self thyroglobulin in autoimmune thyroiditis: thyroiditis transfer with Vbeta8+ T cells. Cell Immunol 2001;212:63-70. [PMID: 11716530 DOI: 10.1006/cimm.2001.1837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
86 Weetman AP. Thyroid Disease. The Autoimmune Diseases. Elsevier; 2006. pp. 467-82. [DOI: 10.1016/b978-012595961-2/50038-x] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
87 Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin Exp Immunol 2004;137:503-12. [PMID: 15320899 DOI: 10.1111/j.1365-2249.2004.02553.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
88 Deshmukh US, Sim DL, Dai C, Kannapell CJ, Gaskin F, Rajagopalan G, David CS, Fu SM. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. J Autoimmun 2011;37:254-62. [PMID: 21868195 DOI: 10.1016/j.jaut.2011.07.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
89 Flynn JC, Meroueh C, Snower DP, David CS, Kong YM. Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 2007;147:547-54. [PMID: 17302906 DOI: 10.1111/j.1365-2249.2006.03303.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
90 Raju R, Zhan W, Karachunski P, Sieck GC, Conti-fine BM, David CS. Susceptibility of HLA DR3 Transgenic Mice to Experimental Autoimmune Myasthenia Gravisa. Annals NY Acad Sci 1998;841:360-4. [DOI: 10.1111/j.1749-6632.1998.tb10947.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]